Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases.
Jacek RyszBeata FranczykJanusz ŁawińskiAnna Gluba-BrzózkaPublished in: Antioxidants (Basel, Switzerland) (2020)
Chronic kidney disease is highly prevalent worldwide. The decline of renal function is associated with inadequate removal of a variety of uremic toxins that exert detrimental effects on cells functioning, thus affecting the cardiovascular system. The occurrence of cardiovascular aberrations in CKD is related to the impact of traditional risk factors and non-traditional CKD-associated risk factors, including anemia; inflammation; oxidative stress; the presence of some uremic toxins; and factors related to the type, frequency of dialysis and the composition of dialysis fluid. Cardiovascular diseases are the most frequent cause for the deaths of patients with all stages of renal failure. The kidney is one of the vital sources of antioxidant enzymes, therefore, the impairment of this organ is associated with decreased levels of these enzymes as well as increased levels of pro-oxidants. Uremic toxins have been shown to play a vital role in the onset of oxidative stress. Hemodialysis itself also enhances oxidative stress. Elevated oxidative stress has been demonstrated to be strictly related to kidney and cardiac damage as it aggravates kidney dysfunction and induces cardiac hypertrophy. Antioxidant therapies may prove to be beneficial since they can decrease oxidative stress, reduce uremic cardiovascular toxicity and improve survival.
Keyphrases
- oxidative stress
- chronic kidney disease
- end stage renal disease
- induced apoptosis
- peritoneal dialysis
- diabetic rats
- ischemia reperfusion injury
- dna damage
- cardiovascular disease
- risk factors
- gene expression
- left ventricular
- heat shock
- endoplasmic reticulum stress
- coronary artery disease
- metabolic syndrome
- cell cycle arrest
- anti inflammatory
- prognostic factors
- signaling pathway